Acute stroke endovascular treatment: Tips and tricks

Acute ischemic stroke is a leading cause of death and disability in the United States, responsible for 1 of every 20 deaths. The effcacy of intravenous tissue plasminogen activator (tPa) alone for recanalization of large-vessel occlusion (lvo) is low. several randomized trials have now established endovascular treatment of lvo as a standard of care. endovascular techniques continue to evolve at a rapid pace. This review seeks to report recent advances in endovascular technology, discuss the correlation between speed of reperfusion and patient outcomes, and present mobile stroke care, shortcoming of the recent technology (such as clot fragmentation), and potential solutions to overcome these drawbacks, as well as anesthetic considerations and cost-effectiveness.